Core Viewpoint - Rosen Law Firm is reminding investors who purchased ModivCare Inc. securities between November 3, 2022, and September 15, 2024, of the March 31, 2025, deadline to become lead plaintiffs in a class action lawsuit [1] Group 1: Class Action Details - Investors who purchased ModivCare securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2][5] - The deadline to move the Court to serve as lead plaintiff is March 31, 2025, with the lead plaintiff acting on behalf of other class members [2] Group 2: Law Firm Credentials - Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time and has been ranked highly for its performance in securities class action settlements [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3] Group 3: Case Allegations - The lawsuit alleges that ModivCare's defendants made materially false and misleading statements and failed to disclose adverse facts regarding the company's business and operations [4] - Specific issues cited include the deterioration of free cash flow due to certain contracts in ModivCare's non-emergency medical transportation segment, which negatively impacted adjusted EBITDA and liquidity [4] - The lawsuit claims that when the true details were revealed, investors suffered damages due to the misleading positive statements made by the defendants [4]